John Connor Wells
8PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jul 02, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma.Chris Labaki, Eddy Saad, Katrine N Madsen
|Apr 17, 2024
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.Eddy Saad, Georges Gebrael, Karl Semaan
|Mar 11, 2022
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.J Connor Wells, Aven Sidhu, Keyue Ding
|Aug 31, 2021
Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer.Kevin Shee, Sumanta K Pal, J Connor Wells
|Apr 30, 2021
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials.Shubham Sharma, J Connor Wells, Wilma M Hopman
|Jan 19, 2021
Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.Chun Loo Gan, Shaan Dudani, J Connor Wells
Pageof 2
Frequent Collaborators
4 joint publications
Toni K Choueiri
2 joint publications
Sumanta K Pal
2 joint publications
Eddy Saad
1 joint publications
Steven M Yip
1 joint publications
Hao-Wen Sim
1 joint publications
Chun Loo Gan
1 joint publications
Nazli Dizman
1 joint publications
Flora Yan
1 joint publications
Aaron Hansen
1 joint publications
Ulka N Vaishampayan
